Study to Evaluate LevoCept, a Long-Acting Reversible Intrauterine

Recruiting

99 years or below

All

Phase 3

1525 participants needed

1 Location

Brief description of study

The primary objective of the study is to assess the contraceptive efficacy (prevention of pregnancy) of LevoCept. The secondary objectives of the study are to assess the following for LevoCept: Safety and tolerability; Return to fertility after LevoCept removal, only for subjects requesting LevoCept removal to become pregnant; Release rate of LNG from the intrauterine system (IUS) and resulting pharmacokinetics of LNG (PK substudy only).

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Contraceptive, intrauterine device (IUD), birth control
Age: 99 years or below
Gender: All

Woman Age 18+ of child bearing age and interested in using an intrauterine device (IUD) for birth control for up to 5 years.

Updated on 04 Aug 2024. Study ID: 844951

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study to Evaluate LevoCept, a Long-Acting Reversible Intrauterine System, for Contraceptive Efficacy Safety and Tolerability.

Brief description of study

Detailed description of study

Eligibility of study

Find a site

Interested in the study